🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Super excited to share the first preprint from Karuna Ganesh Lab! An amazing collaboration with dana_peer, led by the phenomenal andrew moorman @f_cambuli and Ellie Benitez Memorial Sloan Kettering Cancer Center. Progressive #Plasticity during #ColorectalCancer #Metastasis. biorxiv.org/content/10.110…

Important work by colleague Sakti Chakrabarti, MD outlining real world and clinical trial data that supports the use of neoadjuvant PD-1 blockade for locally advanced MSI-H tumors.

Thrilled to see Lauren Henke, MD, MSCI representing our RadOncUH team onstage at #ASTRO23 to announce HyperSight on TrueBeam with Varian (510K pending). This first-in-the-world patient imaging clinical trial & new tech is just the start of the innovations to come ⚡️

Just published! "Top advances of the year: Ovarian Cancer" by Dr. Melissa Lumish MD and Dr. William P. Tew of Team Ovary, Memorial Sloan Kettering Cancer Center 🔗bit.ly/OvarianCATopAd… Key updates: 🔸Mirvetuximab for PROC 🔸First data showing overall survival benefit for PARPi maintenance OncoAlert #gyncsm

Early onset GI cancers will be highlighted at ASCO #GI24 EO-EGC is rising along with CRC. Our results in JNCI show EO-EGC is: ⬆️gastric ⬆️diffuse type 🟰 stage/survival Much still unknown Fantastic collaboration Andrea Cercek Yelena Y. Janjigian MD Steve Maron Memorial Sloan Kettering Cancer Center

#GI24 ASCO Excellent Keynote by Kimmie Ng, MD, MPH highlighting early onset GI Cancers 👏 #CalltoAction 📌 specialized care pathways 📌 universal genetic testing 📌 public health aware 📌 ⬆️research OncoAlert OncoDaily Rachna Shroff, MD, MS, FASCO

As we grow our #HAI pump program University Hospitals, we now offer this option to patients with colorectal liver metastases or intrahepatic cholangiocarcinoma in robotic-assisted fashion! Great application of the 🤖. EA2222 opening soon! Eva Selfridge COLONTOWN Cholangiocarcinoma Foundation ECOG-ACRIN Cancer Research Group

Now published in JAMA Cardiology, we describe the ECG findings in WNBA players and highlight the importance of sport/sex-specific datasets. jamanetwork.com/journals/jamac… Significant findings are below:

Part of Karuna Ganesh’s conclusion during her research presentation on #colorectalcancer progression: “#CRC metastases span an expanded range of canonical intestinal and non-canonical states.” Learn more: bit.ly/3VPwJvF #AACR24

Medical fellow Stefanie Gerstberger presents her research on how colibactin mutation signatures are associated with younger age of onset in #colorectalcancer during a Poster session at #AACR24. Learn more:bit.ly/3Jbuc7i

CRC progression is all about plasticity. Brilliant talk by the amazing dana_peer about this visionary project with Karuna Ganesh! Shout out to the team behind the work Andrew Moorman Ellie Benitez @f_cambuli Cassandra Burdziak Karuna Ganesh Lab #AACR24 #CRC #plasticity

Grateful for ongoing mentorship from Karuna Ganesh and the opportunity to present early findings from our longitudinal study of #microbiome correlates of early age at onset and tumor sidedness in #CRC Memorial Sloan Kettering Cancer Center University Hospitals Case Comp Cancer Ctr

Always inspiring to learn from Kimmie Ng, MD, MPH about ongoing efforts to dissect the drivers of #earlyonset #CRC including an understanding of the birth cohort effect and the need for cross-institution collaboration AACR Mary Beth Terry Yin Cao Case Comp Cancer Ctr

Fantastic kick off event for our Young Adult Oncology Education Series University Hospitals Case Comp Cancer Ctr discussing early onset GI cancers and hereditary cancer syndromes Emily Steinhagen Mike Daunov ChesleyC Lauren Henke, MD, MSCI Madison Conces, MD Rohan Patel, MD, MPH KateDaunov

An analysis of published studies suggests that a longer duration of immune checkpoint inhibitor therapy is associated with a higher incidence of complete response among patients with mismatch repair–deficient cancers. Full correspondence: nej.md/3EXiEpe

Presented at #AACR25: Neoadjuvant PD-1 blockade with dostarlimab led to organ preservation in a high proportion of patients with early-stage mismatch repair–deficient tumors, with no compromise of surgical options. Full study results: nej.md/3EsWcoi  AACR

PD-1 immunotherapy can eliminate the need for surgery in patients with early-stage, DNA mismatch repair-deficient solid cancers, according to results presented by Andrea Cercek, MD: aacr.org/about-the-aacr… #AACR25 Andrea Cercek @MSK_DeptofMed Memorial Sloan Kettering Cancer Center

New research presented by MSK gastrointestinal medical oncologist Yelena Y. Janjigian MD at #AACR25 shows that a simple blood test can help doctors identify which patients are most likely to benefit from #immunotherapy after cancer surgery to remove tumors — potentially preventing the

Organ preservation is possible in a high proportion of patients with dMMR/MSI-H tumors with neoadjuvant PD-1 blockade. Incredible work by Andrea Cercek Mike Foote Luis Diaz at Memorial Sloan Kettering Cancer Center

Congratulations Stefanie Gerstberger, MD PhD! Innovative and brilliant mentorship by Karuna Ganesh on this work describing why we see the colibactin SBS signature enriched in early onset CRC.